_version_ 1783474564870701056
author Vitallé, Joana
Terrén, Iñigo
Orrantia, Ane
Pérez-Garay, Raquel
Vidal, Francesc
Iribarren, José A.
Rodríguez, Carmen
Lirola, Ana M. López
Bernal, Enrique
Zenarruzabeitia, Olatz
Borrego, Francisco
author_facet Vitallé, Joana
Terrén, Iñigo
Orrantia, Ane
Pérez-Garay, Raquel
Vidal, Francesc
Iribarren, José A.
Rodríguez, Carmen
Lirola, Ana M. López
Bernal, Enrique
Zenarruzabeitia, Olatz
Borrego, Francisco
author_sort Vitallé, Joana
collection PubMed
description
format Online
Article
Text
id pubmed-6884514
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-68845142019-12-03 CD300a inhibits CD16-mediated NK cell effector functions in HIV-1-infected patients Vitallé, Joana Terrén, Iñigo Orrantia, Ane Pérez-Garay, Raquel Vidal, Francesc Iribarren, José A. Rodríguez, Carmen Lirola, Ana M. López Bernal, Enrique Zenarruzabeitia, Olatz Borrego, Francisco Cell Mol Immunol Correspondence Nature Publishing Group UK 2019-08-29 2019-12 /pmc/articles/PMC6884514/ /pubmed/31467415 http://dx.doi.org/10.1038/s41423-019-0275-4 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Correspondence
Vitallé, Joana
Terrén, Iñigo
Orrantia, Ane
Pérez-Garay, Raquel
Vidal, Francesc
Iribarren, José A.
Rodríguez, Carmen
Lirola, Ana M. López
Bernal, Enrique
Zenarruzabeitia, Olatz
Borrego, Francisco
CD300a inhibits CD16-mediated NK cell effector functions in HIV-1-infected patients
title CD300a inhibits CD16-mediated NK cell effector functions in HIV-1-infected patients
title_full CD300a inhibits CD16-mediated NK cell effector functions in HIV-1-infected patients
title_fullStr CD300a inhibits CD16-mediated NK cell effector functions in HIV-1-infected patients
title_full_unstemmed CD300a inhibits CD16-mediated NK cell effector functions in HIV-1-infected patients
title_short CD300a inhibits CD16-mediated NK cell effector functions in HIV-1-infected patients
title_sort cd300a inhibits cd16-mediated nk cell effector functions in hiv-1-infected patients
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884514/
https://www.ncbi.nlm.nih.gov/pubmed/31467415
http://dx.doi.org/10.1038/s41423-019-0275-4
work_keys_str_mv AT vitallejoana cd300ainhibitscd16mediatednkcelleffectorfunctionsinhiv1infectedpatients
AT terreninigo cd300ainhibitscd16mediatednkcelleffectorfunctionsinhiv1infectedpatients
AT orrantiaane cd300ainhibitscd16mediatednkcelleffectorfunctionsinhiv1infectedpatients
AT perezgarayraquel cd300ainhibitscd16mediatednkcelleffectorfunctionsinhiv1infectedpatients
AT vidalfrancesc cd300ainhibitscd16mediatednkcelleffectorfunctionsinhiv1infectedpatients
AT iribarrenjosea cd300ainhibitscd16mediatednkcelleffectorfunctionsinhiv1infectedpatients
AT rodriguezcarmen cd300ainhibitscd16mediatednkcelleffectorfunctionsinhiv1infectedpatients
AT lirolaanamlopez cd300ainhibitscd16mediatednkcelleffectorfunctionsinhiv1infectedpatients
AT bernalenrique cd300ainhibitscd16mediatednkcelleffectorfunctionsinhiv1infectedpatients
AT zenarruzabeitiaolatz cd300ainhibitscd16mediatednkcelleffectorfunctionsinhiv1infectedpatients
AT borregofrancisco cd300ainhibitscd16mediatednkcelleffectorfunctionsinhiv1infectedpatients